01 1Midas Pharma
01 1CROTAMITON
01 1Germany
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-11
Pay. Date : 2018-10-04
DMF Number : 33121
Submission : 2018-09-28
Status : Active
Type : II
20
Midas Pharma Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
One of their notable products is CROTAMITON, with a corresponding US DMF Number 33121.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 11, 2019, and payment made on October 04, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
